IPMK and HIV-1 infection: CA P38A, K170A, K203A, and Q219A mutations, combined with T200I, enhanced HIV-1 infection of IPMK KOVector target cells by 230-, 4400-, 19- and 245-fold, respectively (Fig 3C).